Cubist Systematic Strategies’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,087,247
Closed -$18.1M 3408
2024
Q1
$16.8M Sell
1,087,247
-165,469
-13% -$1.87M 0.1% 254
2023
Q4
$11.1M Sell
1,252,716
-299,046
-19% -$2.21M 0.07% 394
2023
Q3
$9.76M Buy
1,551,762
+318,694
+26% +$2.37M 0.07% 391
2023
Q2
$11.6M Buy
1,233,068
+243,909
+25% +$2.42M 0.08% 365
2023
Q1
$9.81M Buy
989,159
+109,303
+12% +$958K 0.06% 465
2022
Q4
$5.64M Buy
879,856
+563,833
+178% +$3.21M 0.03% 911
2022
Q3
$1.76M Buy
316,023
+193,647
+158% +$1.17M 0.01% 2130
2022
Q2
$554K Sell
122,376
-421,203
-77% -$1.8M ﹤0.01% 2985
2022
Q1
$2.9M Buy
543,579
+222,253
+69% +$1.1M 0.02% 1179
2021
Q4
$2.1M Sell
321,326
-203,671
-39% -$1.47M 0.02% 1319
2021
Q3
$3.96M Buy
524,997
+359,253
+217% +$3.04M 0.05% 586
2021
Q2
$1.8M Buy
165,744
+56,026
+51% +$666K 0.02% 1143
2021
Q1
$1.45M Buy
109,718
+109,618
+109,618% +$1.84M 0.02% 1266
2020
Q4
$1K Buy
+100
New +$1.11K ﹤0.01% 2533

Other funds holding HIMS

Cubist Systematic Strategies's HIMS Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Hims & Hers Health (HIMS) in Q2 2024, closing a stake of 1,087,247 shares — an estimated $18.1M sold.

Cubist Systematic Strategies first reported a position in HIMS in Q4 2020 and held it in 14 quarters. The position peaked at $16.8M in Q1 2024. 297 funds tracked by Wall St. Rank hold HIMS as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Hims & Hers Health position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 1,087,247 Hims & Hers Health shares in Q2 2024, an estimated $18.1M.
  • Cubist Systematic Strategies first reported a position in Hims & Hers Health in Q4 2020 and held it in 14 quarters.
  • Cubist Systematic Strategies's Hims & Hers Health position peaked at $16.8M in Q1 2024.
  • 297 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.